Sitagliptin Dose Comparison Study in Patients With Type 2 Diabetes (MK-0431-077)(COMPLETED)

PHASE1CompletedINTERVENTIONAL

Enrollment

103

Participants

Timeline

Start Date

August 24, 2007

Primary Completion Date

June 17, 2008

Study Completion Date

July 1, 2008

Conditions

Type 2 Diabetes

Interventions

DRUG

sitagliptin phosphate

sitagliptin 100 mg tablets q.d. (once daily) for 7 days.

DRUG

sitagliptin phosphate

sitagliptin 200 mg tablets q.d. (once daily) for 7 days.

DRUG

Comparator: Placebo

sitagliptin 100 mg \& 200 mg matching Placebo tablets q.d. (once daily) for 7 days.

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00541229 - Sitagliptin Dose Comparison Study in Patients With Type 2 Diabetes (MK-0431-077)(COMPLETED) | Biotech Hunter | Biotech Hunter